Discovery and Identification of α-Defensins as Low Abundant, Tumor-Derived Serum Markers in Colorectal Cancer
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 129 (1) , 66-73
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
This publication has 42 references indexed in Scilit:
- Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patientsLaboratory Investigation, 2004
- Detection of Prostate Cancer Using Serum Proteomics Pattern in a Histologically Confirmed PopulationJournal of Urology, 2004
- Identification and overexpression of human neutrophil α-defensins (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongueOral Oncology, 2004
- Expression and regulation of antimicrobial peptides in the gastrointestinal tractJournal of Leukocyte Biology, 2003
- Biomarker Discovery and Identification in Laser Microdissected Head and Neck Squamous Cell Carcinoma with ProteinChip® Technology, Two-dimensional Gel Electrophoresis, Tandem Mass Spectrometry, and ImmunohistochemistryMolecular & Cellular Proteomics, 2003
- Modern laser scanning microscopy in biology, biotechnology and medicineAnnals of Anatomy - Anatomischer Anzeiger, 2003
- Proteomic Evaluation of Archival Cytologic Material Using SELDI Affinity Mass SpectrometryAmerican Journal of Clinical Pathology, 2002
- Contribution of Human α-Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral FactorScience, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixturesProstate Cancer and Prostatic Diseases, 1999